At a glance
ClinicalIndex Comparison RecordStandardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of 4 Multiple Rising Oral Doses (2.5 mg to 100 mg) of BI 10773 Tablets in Male and Female Type 2 Diabetic Patients
In Brief
A Phase 1 clinical trial evaluating BI 10773 Placebo and BI 10773 for Diabetes Mellitus, Type 2. Completed, enrolled 48 participants across 1 site.
Detailed Summary
To investigate safety, tolerability, pharmacokinetics and pharmacodynamics of BI 10773 with repeat dosing for eight days and the exploration of the pharmacokinetics and pharmacodynamics of BI 10773 after multiple dosing, including dose proportionality and assessment of steady state.
Study Details
Timeline
Interventions
po taken fasting with 240 mL water
po taken fasting with 240 mL water
po taken fasting with 240 mL water
po taken fasting with 240 mL water
po taken fasting with 240 mL water
po taken fasting with 240 mL water
po taken fasting with 240 mL water
po taken fasting with 240 mL water